These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3256 related articles for article (PubMed ID: 20005686)
21. Functional genomics and proteomics in the clinical neurosciences: data mining and bioinformatics. Phan JH; Quo CF; Wang MD Prog Brain Res; 2006; 158():83-108. PubMed ID: 17027692 [TBL] [Abstract][Full Text] [Related]
22. A multi-class predictor based on a probabilistic model: application to gene expression profiling-based diagnosis of thyroid tumors. Yukinawa N; Oba S; Kato K; Taniguchi K; Iwao-Koizumi K; Tamaki Y; Noguchi S; Ishii S BMC Genomics; 2006 Jul; 7():190. PubMed ID: 16872506 [TBL] [Abstract][Full Text] [Related]
23. Using support vector regression to model the correlation between the clinical metastases time and gene expression profile for breast cancer. Chiu SH; Chen CC; Lin TH Artif Intell Med; 2008 Nov; 44(3):221-31. PubMed ID: 18678474 [TBL] [Abstract][Full Text] [Related]
24. Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures. Rody A; Karn T; Gätje R; Kourtis K; Minckwitz G; Loibl S; Munnes M; Ruckhäberle E; Holtrich U; Kaufmann M; Ahr A Zentralbl Gynakol; 2006 Apr; 128(2):76-81. PubMed ID: 16673249 [TBL] [Abstract][Full Text] [Related]
25. Selection of relevant genes in cancer diagnosis based on their prediction accuracy. Maglietta R; D'Addabbo A; Piepoli A; Perri F; Liuni S; Pesole G; Ancona N Artif Intell Med; 2007 May; 40(1):29-44. PubMed ID: 16920342 [TBL] [Abstract][Full Text] [Related]
26. Increased expression of urokinase-type plasminogen activator mRNA determines adverse prognosis in ErbB2-positive primary breast cancer. Urban P; Vuaroqueaux V; Labuhn M; Delorenzi M; Wirapati P; Wight E; Senn HJ; Benz C; Eppenberger U; Eppenberger-Castori S J Clin Oncol; 2006 Sep; 24(26):4245-53. PubMed ID: 16963728 [TBL] [Abstract][Full Text] [Related]
27. Molecular classification and molecular forecasting of breast cancer: ready for clinical application? Brenton JD; Carey LA; Ahmed AA; Caldas C J Clin Oncol; 2005 Oct; 23(29):7350-60. PubMed ID: 16145060 [TBL] [Abstract][Full Text] [Related]
28. Meta-analysis of gene expression profiles related to relapse-free survival in 1,079 breast cancer patients. Györffy B; Schäfer R Breast Cancer Res Treat; 2009 Dec; 118(3):433-41. PubMed ID: 19052860 [TBL] [Abstract][Full Text] [Related]
29. The classification of cancer based on DNA microarray data that uses diverse ensemble genetic programming. Hong JH; Cho SB Artif Intell Med; 2006 Jan; 36(1):43-58. PubMed ID: 16102956 [TBL] [Abstract][Full Text] [Related]
30. A gene expression signature identifies two prognostic subgroups of basal breast cancer. Sabatier R; Finetti P; Cervera N; Lambaudie E; Esterni B; Mamessier E; Tallet A; Chabannon C; Extra JM; Jacquemier J; Viens P; Birnbaum D; Bertucci F Breast Cancer Res Treat; 2011 Apr; 126(2):407-20. PubMed ID: 20490655 [TBL] [Abstract][Full Text] [Related]
31. Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome. Ross JS Adv Anat Pathol; 2009 Jul; 16(4):204-15. PubMed ID: 19546609 [TBL] [Abstract][Full Text] [Related]
32. Penalized Cox regression analysis in the high-dimensional and low-sample size settings, with applications to microarray gene expression data. Gui J; Li H Bioinformatics; 2005 Jul; 21(13):3001-8. PubMed ID: 15814556 [TBL] [Abstract][Full Text] [Related]
33. Predicting features of breast cancer with gene expression patterns. Lu X; Lu X; Wang ZC; Iglehart JD; Zhang X; Richardson AL Breast Cancer Res Treat; 2008 Mar; 108(2):191-201. PubMed ID: 18297396 [TBL] [Abstract][Full Text] [Related]
34. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Györffy B; Lanczky A; Eklund AC; Denkert C; Budczies J; Li Q; Szallasi Z Breast Cancer Res Treat; 2010 Oct; 123(3):725-31. PubMed ID: 20020197 [TBL] [Abstract][Full Text] [Related]
36. Multi-platform data integration in microarray analysis. Tsiliki G; Zervakis M; Ioannou M; Sanidas E; Stathopoulos E; Potamias G; Tsiknakis M; Kafetzopoulos D IEEE Trans Inf Technol Biomed; 2011 Nov; 15(6):806-12. PubMed ID: 22113338 [TBL] [Abstract][Full Text] [Related]
37. Development of 95-gene classifier as a powerful predictor of recurrences in node-negative and ER-positive breast cancer patients. Naoi Y; Kishi K; Tanei T; Tsunashima R; Tominaga N; Baba Y; Kim SJ; Taguchi T; Tamaki Y; Noguchi S Breast Cancer Res Treat; 2011 Aug; 128(3):633-41. PubMed ID: 20803240 [TBL] [Abstract][Full Text] [Related]
38. [Gene expression profiling in cancer research]. Michiels S; Koscielny S; Boulet T; Hill C Bull Cancer; 2007 Nov; 94(11):976-80. PubMed ID: 18055315 [TBL] [Abstract][Full Text] [Related]
39. Integration of pathway knowledge into a reweighted recursive feature elimination approach for risk stratification of cancer patients. Johannes M; Brase JC; Fröhlich H; Gade S; Gehrmann M; Fälth M; Sültmann H; Beissbarth T Bioinformatics; 2010 Sep; 26(17):2136-44. PubMed ID: 20591905 [TBL] [Abstract][Full Text] [Related]
40. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management. Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]